Mode 2 knowledge production: Evidence from orphan drug networks

Science and Public Policy

Volumn 34, Issue 3, 2007, Pages 199-211

  Crompton, Helen ^a  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DEVELOPMENT; EMPIRICAL ANALYSIS; INNOVATION; KNOWLEDGE; LOCAL PARTICIPATION; ORPHAN; POLICY MAKING; SCIENCE AND TECHNOLOGY;

EID: 34548206731     PISSN: 03023427     EISSN: None     Source Type: Journal    
DOI: 10.3152/030234207X197066     Document Type: Article

References (54)

1. Bijker, W E 1995. Of Bicycles, Bakelites and Bulbs: toward a Theory of Technological Change Cambridge: MIT Press.
2. Brownlee, S 2003. Health, hope and hype: why the media oversells medical breakthroughs. Washington Post, 3 August.
3. Burton, B 2003. Australia opts to label drugs developed through stem cell research. British Medical Journal, 327(7417), 700.
4. Callon, M, J Law and A Rip 1986. Mapping the Dynamic of Research. London: Macmillan.
5. Castells, M 1989, 2000. The Informational City: Information Technology, Economic Re-structuring and the Urban Regional Process, Oxford: Blackwell.
6. Collins, H M and R Evans 2002. The third wave of science studies: studies of expertise and experience. Social Studies of Science, 32(2), 235-296.
7. Duckenfield, D 2002. Patient Power? Patient Group Influence in the Drug Approval Process in the UK. Paper prepared for the 2002 Annual Meeting of the Political Studies Association, Aberdeen, 5-7 April 2002.
8. EPPOSI, European Partnership of Patients Organizations, Science and Industry 2002. Report of the 2nd EPPOSI Workshop on Rare Disease Therapy Development and Partnering: Patients in Partnership with Science Industry and Venture Capital.
9. Epstein, S 1996. Impure Science; AIDS, Activism, and the Politics of Knowledge. Berkeley, CA: University of California Press.
10. Fleischer-Black, M 2002. Patient, Heal Thyself. Available at , last accessed 24 July 2002.
11. Frederikson, F, F Hansson and S Wenneberg 2001. Knowledge Assessment in the Agora, MPP Working Paper No. 14/2001, Copenhagen Business School.
12. Friedman, K A 1994. An Informational Report on Citizen Advisory Groups. Available at , last accessed 23 April 2004.
13. French, H 2006. Life Sciences Update. Bird & Bird, March 2006. Available at , last accessed 23 March 2006.
14. Gibbons, M 1999. Science's new social contract with society, Nature, 402, C81-C84.
15. Gibbons, M 2000. Innovation and the Developing System of Knowledge Production. Available at , last accessed 12 November 2004.
16. Gibbons, M, C Limoges, H Nowotny, S Schwartzman, P Scott and M Trow 1994. The New Production of Knowledge: The Dynamics of Science and Research in Contemporary Societies, London: Sage.
17. Godin, B 1998. Writing performative history: a new Atlantis? Social Studies of Science, 28(3), 465-483.
18. Haffner, M E 2006. Adopting orphan drugs - two dozen years of treating rare diseases. New England Journal of Medicine, 354, 445-447.
19. Henkel, P 1999. Orphan Drug Law Matures into Medical Mainstay. Available at , last accessed 15 February 2007.
20. Jones, O, F Steward and S Conway 2001. Social Interaction and Organisational Change: Aston Perspectives on Innovation Networks, London: Imperial College Press.
21. Joss, S 1998. Danish consensus conferences as a model in participatory technology assessment: an impact study of consensus conferences on Danish parliament and Danish public debate. Science and Public Policy, 25(1), 2-22.
22. Latour, B 1999. On recalling ANT. In Actor Network Theory and After, eds. J Law and J Hassard, pp. 18-23. Oxford: Blackwell.
23. Lave, J and E Wenger 1991. Situated Learning: Legitimate Peripheral Participation, Cambridge: Cambridge University Press.
24. Lieff- Benderly, B 2004. Advocacy groups are crucial players in developing new neurotherapeutics, NeuroRx, 1, 500-502. Available at , last accessed 16 May 2004.
25. Merton, R K 1973. The normative structure of science. In The Sociology of Science: Theoretical and Empirical Investigations, ed. R K Merton, pp. 267-278. Chicago: Chicago University Press.
26. Meyers, A 1999. How TV Launched the Orphan Drug Law. Available at , last accessed 20 October 2006.
27. Miller, W L and B F Crabtree 1994. Clinical research. In Handbook of Qualitative Research, eds. N K Denzin and Y S Lincoln, pp.607-631. Thousand Oaks: Sage.
28. Nonaka, I and N Konno 1998. The concept of 'ba': building a foundation for knowledge creation, California Management Review, 40(3), 40-54.
29. Nowotny, H 1993. Socially distributed knowledge: five spaces for science to meet the public. Public Understanding of Science, 2, 307-319.
30. Nowotny, H, P Scoff and M Gibbons 2001. Re-Thinking Science: Knowledge and the Public in an Age of Uncertainty, Cambridge: Polity Press.
31. Nowotny, H, P Scott and M Gibbons 2003. Mode 2 Revisited: the New Production of Knowledge. Available at , last accessed 5 July 2003.
32. Odone, C 2002. Lorenzo's triumph. Daily Mail, 6 October.
33. Oliver, R W 1999. The Coming Biotech Age: the Business of Bio-Material. New York: McGraw-Hill.
34. Olson, G M, J S Olson and R E Kraut 1992. Introduction to this special issue on computer-supported co-operative work, Human-Computer Interaction, 17, 251-256.
35. Powell, W W 1998. Learning from collaboration: knowledge and networks in the biotechnology and pharmaceutical industries, California Management Review, 40(3), 228-240.
36. Powell, W W, K Koput and W Smith-Doerr 1996. Interorganisational collaboration and the locus of innovation: networks of learning in biotechnology. Administrative Science Quarterly, 41, 116-145.
37. Rabeharisoa, V 2003. The struggle against neuromuscular diseases in France and the emergence of the 'partnership model' of patient organization. Social Science and Medicine, 57(11), 2127-2136.
38. Rabeharsioa, V 2006. From representation to mediation: the shaping of collective mobilization on muscular dystrophy in France. Social Science and Medicine, 62(3), 564-576.
39. Reardon, D 2002. President of regulatory affairs, orphan medical, quoted in Business Week Online. Available at , last accessed 13 December 2002.
40. Reaves, N D 2001. Innovation, Regulation and Orphan Drugs. Available at , Paper No. 56, last accessed 24 November 2004.
41. Redwood, H 2002. Patients, Doctors and the Internet: A Question of Trust. Available at , last accessed 12 April 2003.
42. Rifkin, J 1998. The Biotech Century: Harnessing the Gene and Remaking the World. York: Jeremy P Tarcher/Putnam.
43. Rohde, D D 2000. The Orphan Drug Act: an engine of innovation? At what cost? Food and Drug Law Journal, 55, 125-143.
44. Sauer, F 2000. New Drugs in the Global Economy: Risk Assessment and Risk Management in the EU and Co-operation with the USA, University of Pittsburgh, 13 November 2000. Available at , last accessed 16 July 2002.
45. Schuhsler, F 2003. A case for investing in biotechnology. Biotechnology Investors' Forum - Europe. Available at , last accessed 22 January 2004.
46. Shinn, T 2002. The triple helix and the new production of knowledge: prepacked thinking on science and technology. Social Studies of Science, 32(4), 599-614.
47. Tidd, J, J Bessant and K Pavitt 2001. Managing Innovation: Integrating Technological, Market and Organizational Change, 2nd edn. Chichester: John Wiley & Sons.
48. Torrent-Farnell, J (2001). Notes taken at the Management Forum seminar, 'Orphan Drug Designation: Current Status in the EU', London, on 19 November 2001.
49. Uhlin, A, J Rangnes and M Synnevag 2000. The Third Triple Helix Conference - The Endless Transition: Modelling and Facilitating Prospective Innovation Systems. Available at , last accessed 7 November 2000.
50. Ursin, J 2000. Group Dynamics in the Production of New Knowledge - a Theoretical Framework. Paper presented at the European Conference on Educational Research, Edinburgh, 20-23 September 2002.
51. Walsh, V 2002. Creating markets for biotechnology. International Journal of Sociology of Agriculture and Food, 10(2), 33-45.
52. Weingart, P 1997. From 'Finalisation' to 'Mode 2': old wine in new bottles. Social Science Information, 36(4), 591-613.
53. Yin, R K 1994. Case Study Research. Thousand Oaks, Sage.
54. Youngs, C 2001. Newsletter No 7. Spring 2001. Available at , last accessed 20 November 2003.